{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:20:56Z","timestamp":1791267656977,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/cco.0b013e328349ab8d","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T03:09:34Z","timestamp":1310612974000},"page":"441-448","source":"Crossref","is-referenced-by-count":38,"title":["Splenic marginal zone B-cell lymphoma"],"prefix":"10.1097","volume":"23","author":[{"given":"A.","family":"Traverse-Glehen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Baseggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Felman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.","volume":"100","author":"Chacon","year":"2002","journal-title":"Blood"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","article-title":"Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients.","volume":"120","author":"Parry-Jones","year":"2003","journal-title":"Br J Haematol"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients.","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity.","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","article-title":"Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.","volume":"100","author":"Arcaini","year":"2004","journal-title":"Cancer"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cncr.20596","article-title":"Splenic marginal zone lymphoma with or without villous lymphocytes: hematologic findings and outcomes in a series of 57 patients.","volume":"101","author":"Iannitto","year":"2004","journal-title":"Cancer"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1002\/cncr.25325","article-title":"Marginal zone lymphomas: factors that affect the final outcome.","volume":"116","author":"Mazloom","year":"2010","journal-title":"Cancer"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","article-title":"The histopathology of splenic lymphoma with villous lymphocytes.","volume":"84","author":"Isaacson","year":"1994","journal-title":"Blood"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199510000-00005","article-title":"Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.","volume":"19","author":"Mollejo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.pas.0000213419.08009.b0","article-title":"Splenic marginal-zone lymphoma: one or more entities A histologic, immunohistochemical, and molecular study of 42 cases.","volume":"31","author":"Papadaki","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.humpath.2009.09.007","article-title":"Defining the borders of splenic marginal zone lymphoma: a multiparameter study.","volume":"41","author":"Dufresne","year":"2010","journal-title":"Hum Pathol"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00000478-199605000-00008","article-title":"Splenic marginal zone lymphoma: a distinct B-cell neoplasm.","volume":"20","author":"Hammer","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00000478-200012000-00001","article-title":"Splenic marginal zone lymphoma with or without plasmacytic differentiation.","volume":"24","author":"Van Huyen","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.1996.d01-536.x","article-title":"Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma.","volume":"29","author":"Franco","year":"1996","journal-title":"Histopathology"},{"key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1600-0609.2005.00624.x","article-title":"Intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study.","volume":"76","author":"Pich","year":"2006","journal-title":"Eur J Haematol"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1046\/j.1365-2141.2002.03934.x","article-title":"Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypes.","volume":"119","author":"Costes","year":"2002","journal-title":"Br J Haematol"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1309\/HRHQFBFTR8B4LXT4","article-title":"Bone marrow involvement by marginal zone B-cell lymphomas of different types.","volume":"129","author":"Inamdar","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdn563","article-title":"Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients.","volume":"20","author":"Boveri","year":"2009","journal-title":"Ann Oncol"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3324\/haematol.2009.011049","article-title":"CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.","volume":"95","author":"Baseggio","year":"2010","journal-title":"Haematologica"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2141.2010.08347.x","article-title":"Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.","volume":"151","author":"Rinaldi","year":"2010","journal-title":"Br J Haematol"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","article-title":"Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.","volume":"95","author":"Zibellini","year":"2010","journal-title":"Haematologica"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","article-title":"Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.","volume":"3","author":"Thieblemont","year":"2002","journal-title":"Clin Lymphoma"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/sj.leu.2403440","article-title":"Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.","volume":"18","author":"Lefrere","year":"2004","journal-title":"Leukemia"},{"key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009054887","article-title":"Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes.","volume":"40","author":"Lefrere","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hon.820","article-title":"Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.","volume":"25","author":"Kalpadakis","year":"2007","journal-title":"Hematol Oncol"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.","volume":"25","author":"Camacho","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.2008.07301.x","article-title":"High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis.","volume":"143","author":"Dungarwalla","year":"2008","journal-title":"Br J Haematol"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use.","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"key":"R35-5-20210128","first-page":"2789","article-title":"Splenic marginal zone B cells in humans: where do they mutate their Ig receptor Eur J I","volume":"35","author":"Weller","year":"2005","journal-title":"mmunol"},{"key":"R36-5-20210128","first-page":"2253","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity B","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"lood"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/leu.2010.44","article-title":"Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.","volume":"24","author":"Hockley","year":"2011","journal-title":"Leukemia"},{"key":"R38-5-20210128","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2141.2009.07962.x","article-title":"Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns.","volume":"148","author":"Hockley","year":"2010","journal-title":"Br J Haematol"},{"key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.42.6.567","article-title":"Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.","volume":"42","author":"Bennett","year":"1989","journal-title":"J Clin Pathol"},{"key":"R40-5-20210128","first-page":"113","article-title":"Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity Br J H","volume":"150","author":"Traverse-Glehen","year":"2010","journal-title":"aematol"},{"key":"R41-5-20210128","first-page":"2253","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinico-pathological and molecular entity B","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"lood"},{"key":"R42-5-20210128","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","article-title":"Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features.","volume":"95","author":"Kanellis","year":"2010","journal-title":"Haematologica"},{"key":"R43-5-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia.","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"R44-5-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hon.957","article-title":"Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).","volume":"29","author":"Baseggio","year":"2011","journal-title":"Hematol Oncol"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCO.0b013e328349ab8d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:37:29Z","timestamp":1786045049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-201109000-00005"}},"subtitle":["a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification"],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e328349ab8d","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}